Workflow
医药商业板块9月5日涨0.4%,百洋医药领涨,主力资金净流出1635.01万元

Market Performance - The pharmaceutical commercial sector increased by 0.4% compared to the previous trading day, with Baiyang Pharmaceutical leading the gains [1] - On the same day, the Shanghai Composite Index closed at 3812.51, up 1.24%, while the Shenzhen Component Index closed at 12590.56, up 3.89% [1] Individual Stock Performance - Baiyang Pharmaceutical (301015) closed at 27.16, with a rise of 4.14% and a trading volume of 108,200 shares, amounting to a transaction value of 287 million yuan [1] - Other notable performers included Guofang Co. (600538) with a 2.14% increase, and Runda Medical (603108) with a 1.79% increase [1] - Conversely, Selin Medical (603716) saw a decline of 1.21%, with a trading volume of 289,200 shares and a transaction value of 809 million yuan [2] Capital Flow Analysis - The pharmaceutical commercial sector experienced a net outflow of 16.35 million yuan from institutional investors, while retail investors saw a net inflow of 11.97 million yuan [2] - The data indicates that retail investors are showing interest in the sector despite the overall net outflow from institutional investors [2] Detailed Capital Flow for Selected Stocks - Runda Medical (603108) had a net inflow of 16.55 million yuan from institutional investors, while it faced a net outflow of 10.39 million yuan from retail investors [3] - China Medical (600056) also saw significant institutional inflows of 15.68 million yuan, but retail investors withdrew 5.26 million yuan [3] - Baiyang Pharmaceutical (301015) had a net inflow of 12.71 million yuan from institutional investors, with retail investors withdrawing 11.58 million yuan [3]